https://www.selleckchem.com/pr....oducts/Temsirolimus.
4 months with thrombocytosis vs. 34.4 months without, p less then 0.01). While non-White women had shorter median OS for the whole cohort in the setting of thrombocytosis (29.4 months vs. 39.6 months, p less then 0.01), among those with uterine serous carcinoma (USC), this finding was reversed, with decreased median OS in White women (22.1 vs. 16.4 months, p = 0.01). Thrombocytosis is concluded to have negative associations with OS and patient race.Bi2Se3 possesses a two-dimensional layered rhombohedral crystal structure, where the